hotspot -WSS

hotspot

author：fashion 2025-09-30 18:58:45 - browse：3

Susan Galbraith of AstraZeneca gestures while speaking – pharma coverage from STAT — Susan Galbraith, AstraZeneca’s head of cancer research and development, speaks at a STAT event in 2023. Marie Miller for STAT

CHICAGO — AstraZeneca’s head of cancer research and development, Susan Galbraith, is British, and prone to a particularly British style of understatement. She doesn’t boast loudly. But she did come to this year’s annual meeting of the American Society of Clinical Oncology wearing a small lapel pin with the numeral 6 and the “AZ” corporate logo.

That pin represents the number of years in a row that the London-based drug giant has had a presentation in the ASCO plenary, the conference’s biggest showcase for new data. This year, the company has two.

Scientific credibility is great, of course. But AstraZeneca’s shareholders want something else: return on investment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Neurocrine congenital adrenal hyperplasia trial succeeds

WSS

House panel takes first step toward fixing drug shortages

Transgender sports debate: Physicians say bans are health issue

With competition flaring, obesity drug hits goal in liver disease study

The struggle to figure out which patients 'deserve' Wegovy

Why the quest to eradicate polio has stumbled

House panel takes first step toward fixing drug shortages

Wikipedia

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

As demand for Covid shots wanes, Moderna seeks its next success

Eli Lilly CEO gives to Mike Pence presidential super PAC

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Information blocking fines are now fair game in health care

Walensky prepares to leave CDC — and Congress — behind

Transgender sports debate: Physicians say bans are health issue

Heart attack and stroke risk calculators need revising

Dario to buy mental health app maker Twill in cash and stock deal

Tori Bowie and the unacceptable rates of Black maternal death

Obesity drugs seen as possible treatment for liver disease MASH

focus

'A game

Alabama IVF ruling threatens families facing fatal genetic disease

Information blocking fines are now fair game in health care

Akili changes sales model for its ADHD video game treatment

Why the drug industry's warnings on the IRA's impact fall short

Medicare inequities exacerbate Puerto Rico’s health disparities

focus

focus

hotspot

Wikipedia